Skip to content
logo of the National Blood Authority
AUSTRALIAN
HAEMOVIGILANCE
REPORT
A report by the National Blood Authority Haemovigilance Advisory Committee
DATA FOR 2011-12 AND 2012-13
You are here:
Index » Executive summary

Executive summary

This is the fourth national Australian Haemovigilance Report. It provides an overview of blood transfusion and donation-related adverse events in Australia, and recent data and information on fresh blood product issues. The report also delivers 10 key recommendations in the areas of:

  • national blood quality and safety initiatives
  • reducing human errors
  • data standards
  • reporting capacity.
Back to Top

In this section

  • Haemovigilance data for 2011-12 and 2012-13
  • Donor vigilance data for 2012–13
  • Fresh blood product issue data
  • Recommendations
Message from the General Manager of the National Blood Authority up Haemovigilance data for 2011-12 and 2012-13

Table of contents

  • Index
    • Australian Haemovigilance Report
    • Caveat
    • Message from the General Manager of the National Blood Authority
    • Executive summary
      • Haemovigilance data for 2011-12 and 2012-13
      • Donor vigilance data for 2012–13
      • Fresh blood product issue data
      • Recommendations
    • Part 01 Haemovigilance data for 2011-12 and 2012-13
    • Part 02 Recommendations
    • Part 03 Donor Vigilance
    • Part 04 Previous Australian haemovigilance report performance
    • Part 05 Fresh blood product use and haemovigilance systems
    • Appendix I: International context
    • Appendix II: Definitions in haemovigilance
    • Appendix III: Definitions of donor adverse events
    • Appendix IV: incident severity rating and reporting
    • Abbreviations and acronyms
    • Acknowledgements
    • References
National Blood Authority website
© Commonwealth of Australia